Market Cap 2.26B
Revenue (ttm) 36.50M
Net Income (ttm) 673.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,845.84%
Debt to Equity Ratio 0.00
Volume 717,000
Avg Vol 595,008
Day's Range N/A - N/A
Shares Out 57.92M
Stochastic %K 88%
Beta 0.73
Analysts Strong Sell
Price Target $51.71

Company Profile

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 649 8600
Address:
88 Sidney Street, Cambridge, United States
Jadek6
Jadek6 Jul. 14 at 9:09 PM
$AGIO How many more fancy BS hires do these misfits , Fouse and Goff, need to get their products in the faces of Dr. Or countries Kristhnan , that failure was just hired , a loser other places Now this Backstrom is added with free options WHILE MILANOVA another Matketing clown since 2023 3 clownes supposedly working on the ,marketing end and Avanzanite .another marketing company added , taking a cut , that’s fcuked up, AND…..NO RESULTS SHALL WE HIRE LEE IACOCCA ? To help turn this disaster around , or Jack Welch ? 3 clowns and Avanzanite are sucking wind.
0 · Reply
Blufffolio
Blufffolio Jul. 14 at 3:16 PM
$AGIO ⁨WKSP: Vol breakout & HL at $3.00 = solid base. Gap to $5.50 still a magnet. Tesla tests confirm. Margins climbing. Float razor-thin. Below-forecast rev = bargain play. Watch $3 support & gap squeeze loading…⁩
0 · Reply
Tumble51
Tumble51 Jul. 14 at 11:55 AM
$AGIO ahahahahahahaha RED. RED. RED already News is out the chief medical officer In charge of trials that : Collects data… Visits sites… Writes reports … Discussions with FDA , no advisory meeting Sees everything, hears the FDA questions and concerns Responses to FDA questions Receives FDA responses and tone of response Sells stock before Sept 7 2025 OH BOY …GOFF is in deep do do Oh no he is not …He sold shares in June 2025 , dec 2024
0 · Reply
Tumble51
Tumble51 Jul. 13 at 4:36 PM
$PLTR NO BALLS Cantor Fitz ..LUTNICK cant even figure out one country has only penguins !!! Called $AGIO and OUTPERFORM in 2024 at $32 ..hahahah Now $35 ..OH BOY Losers always surround themselves with bigger losers TRUMP and LUTNICK
0 · Reply
Tumble51
Tumble51 Jul. 13 at 4:20 PM
$AGIO Another run here this week as usual, aided by Morgan Stanley for , get this, Sarah G. Head of medical affairs and FDA submissions ..oh boy , knowing the facts. Writing up the data, accumulating the data, conversations with the FDA, she SELLS ! OH BOY ! Goff , ceo , sold last month , oh boy Total misfits …sucking on the HUGE TIT ! Already gone thru 1.8 B and on to the 1B from Servier and getting an approval on another cancer drug , Vorasidenib. None of which these 3 bozos were par of…where is their drug ? Oh I know , welfare ..from the oncology part , sold off like an auction. Selling parts to supplement their existence and sucking down on it ! While these clowns here have got nothing approved , lol
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Jul. 12 at 3:50 PM
FY2026 revenue multiples for all 29 comm'l-stage (or almost comm'l-stage) oncology (MCs $200MM+) & all 55 non-oncology (MC's $600MM+) focused bios. $IOVA trades at the lowest FY26 revenue multiple (excl those with recent bad news like SRPT). A data read in certain lung cancers is imminent. If the data is compelling then the TIL TAM would dramatically increase. We'd guess near-term M&A candidates include: $JAZZ (JAZZ's EV is ~$3B more than market cap...multiples are based on market cap). $TARS $TGTX $AGIO We track these data points manually so we could have made a mistake. Otherwise, this is just for fun for entertainment purposes only. We have no idea who is most likely to be acquired.
3 · Reply
Dkll303
Dkll303 Jul. 11 at 12:58 PM
$AGIO RED …hahaha ..on a quick short this AM
0 · Reply
Cryvantis
Cryvantis Jul. 10 at 11:58 AM
$AGIO He’s right - no hype when WKSP dips. But here’s why it’s still a winner: - Last-mile EV leader: Electric delivery vans with range & payload on par with diesel. - Big-name contracts: UPS, USPS & more secured for years. - Proprietary batteries: Faster charging, longer life. - Drone fleet integration: Ground trucks + aerial drones = unmatched delivery network. - Green incentives: Subsidies & tax breaks boost margins. …and then they’ll chase the high price.
0 · Reply
Dkll303
Dkll303 Jul. 9 at 5:36 PM
$AGIO Member here since June 2024 Most important facts were glanced over Senior execs are far from competent Bothe were without jobs Fouse as CEO, failed here ..goff in 3 years has done nothing but sell options Money in the treasury is from selling royalties up front to keep their jobs intact What is next when the misfits have auctioned off parts of the whole to continue their incompetence to deliver
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 2:07 PM
$AGIO Really good write-up that perfectly summarizes AGIO's present situation. So if you want to bring your AGIO knowledge up to date or just discover AGIO, this is required reading. https://beyondspx.com/article/agios-cellular-metabolism-expertise-powers-rare-disease-ambitions-towards-a-breakout-year-nasdaq-agio
0 · Reply
Latest News on AGIO
Agios Appoints Dr. Jay Backstrom to Board of Directors

Jul 8, 2025, 7:00 AM EDT - 7 days ago

Agios Appoints Dr. Jay Backstrom to Board of Directors


Agios to Present at Upcoming Investor Conferences

Mar 4, 2025, 7:00 AM EST - 4 months ago

Agios to Present at Upcoming Investor Conferences


Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment

Aug 27, 2024, 10:18 AM EDT - 11 months ago

Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment


Agios Pharmaceuticals (AGIO) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 2:08 PM EST - 1 year ago

Agios Pharmaceuticals (AGIO) Q4 2023 Earnings Call Transcript


Agios Is A Gem, But It Will Need Patience (Rating Upgrade)

Jan 8, 2024, 8:00 AM EST - 1 year ago

Agios Is A Gem, But It Will Need Patience (Rating Upgrade)


Jadek6
Jadek6 Jul. 14 at 9:09 PM
$AGIO How many more fancy BS hires do these misfits , Fouse and Goff, need to get their products in the faces of Dr. Or countries Kristhnan , that failure was just hired , a loser other places Now this Backstrom is added with free options WHILE MILANOVA another Matketing clown since 2023 3 clownes supposedly working on the ,marketing end and Avanzanite .another marketing company added , taking a cut , that’s fcuked up, AND…..NO RESULTS SHALL WE HIRE LEE IACOCCA ? To help turn this disaster around , or Jack Welch ? 3 clowns and Avanzanite are sucking wind.
0 · Reply
Blufffolio
Blufffolio Jul. 14 at 3:16 PM
$AGIO ⁨WKSP: Vol breakout & HL at $3.00 = solid base. Gap to $5.50 still a magnet. Tesla tests confirm. Margins climbing. Float razor-thin. Below-forecast rev = bargain play. Watch $3 support & gap squeeze loading…⁩
0 · Reply
Tumble51
Tumble51 Jul. 14 at 11:55 AM
$AGIO ahahahahahahaha RED. RED. RED already News is out the chief medical officer In charge of trials that : Collects data… Visits sites… Writes reports … Discussions with FDA , no advisory meeting Sees everything, hears the FDA questions and concerns Responses to FDA questions Receives FDA responses and tone of response Sells stock before Sept 7 2025 OH BOY …GOFF is in deep do do Oh no he is not …He sold shares in June 2025 , dec 2024
0 · Reply
Tumble51
Tumble51 Jul. 13 at 4:36 PM
$PLTR NO BALLS Cantor Fitz ..LUTNICK cant even figure out one country has only penguins !!! Called $AGIO and OUTPERFORM in 2024 at $32 ..hahahah Now $35 ..OH BOY Losers always surround themselves with bigger losers TRUMP and LUTNICK
0 · Reply
Tumble51
Tumble51 Jul. 13 at 4:20 PM
$AGIO Another run here this week as usual, aided by Morgan Stanley for , get this, Sarah G. Head of medical affairs and FDA submissions ..oh boy , knowing the facts. Writing up the data, accumulating the data, conversations with the FDA, she SELLS ! OH BOY ! Goff , ceo , sold last month , oh boy Total misfits …sucking on the HUGE TIT ! Already gone thru 1.8 B and on to the 1B from Servier and getting an approval on another cancer drug , Vorasidenib. None of which these 3 bozos were par of…where is their drug ? Oh I know , welfare ..from the oncology part , sold off like an auction. Selling parts to supplement their existence and sucking down on it ! While these clowns here have got nothing approved , lol
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Jul. 12 at 3:50 PM
FY2026 revenue multiples for all 29 comm'l-stage (or almost comm'l-stage) oncology (MCs $200MM+) & all 55 non-oncology (MC's $600MM+) focused bios. $IOVA trades at the lowest FY26 revenue multiple (excl those with recent bad news like SRPT). A data read in certain lung cancers is imminent. If the data is compelling then the TIL TAM would dramatically increase. We'd guess near-term M&A candidates include: $JAZZ (JAZZ's EV is ~$3B more than market cap...multiples are based on market cap). $TARS $TGTX $AGIO We track these data points manually so we could have made a mistake. Otherwise, this is just for fun for entertainment purposes only. We have no idea who is most likely to be acquired.
3 · Reply
Dkll303
Dkll303 Jul. 11 at 12:58 PM
$AGIO RED …hahaha ..on a quick short this AM
0 · Reply
Cryvantis
Cryvantis Jul. 10 at 11:58 AM
$AGIO He’s right - no hype when WKSP dips. But here’s why it’s still a winner: - Last-mile EV leader: Electric delivery vans with range & payload on par with diesel. - Big-name contracts: UPS, USPS & more secured for years. - Proprietary batteries: Faster charging, longer life. - Drone fleet integration: Ground trucks + aerial drones = unmatched delivery network. - Green incentives: Subsidies & tax breaks boost margins. …and then they’ll chase the high price.
0 · Reply
Dkll303
Dkll303 Jul. 9 at 5:36 PM
$AGIO Member here since June 2024 Most important facts were glanced over Senior execs are far from competent Bothe were without jobs Fouse as CEO, failed here ..goff in 3 years has done nothing but sell options Money in the treasury is from selling royalties up front to keep their jobs intact What is next when the misfits have auctioned off parts of the whole to continue their incompetence to deliver
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 2:07 PM
$AGIO Really good write-up that perfectly summarizes AGIO's present situation. So if you want to bring your AGIO knowledge up to date or just discover AGIO, this is required reading. https://beyondspx.com/article/agios-cellular-metabolism-expertise-powers-rare-disease-ambitions-towards-a-breakout-year-nasdaq-agio
0 · Reply
Dkll303
Dkll303 Jul. 9 at 11:19 AM
$AGIO the reasons have existed since the Hire of Fouse in Dec 2018 ..a crony buddy of Schenkien’s. Who he, has retired from the board after he lied to wall st in 2015. Then Goff comes in , another laid off hack from Alexion and not their CEO, a middle mgnr . And 2 years later ? Just a sucking sound of him selling options every chance he gets , recently in June ! Real bunch of misfits ….you got your answer @Inoa
0 · Reply
lnoa
lnoa Jul. 8 at 12:16 PM
$AGIO no one wants to buy this comp? Long time lagging!! Stuck here..🥲
0 · Reply
Dkll303
Dkll303 Jul. 8 at 11:54 AM
$AGIO try to get the PM correct , lol .. It is RED on 228 shares Play catch-up , Stocktwits a bit better The NYSE/NASDAQ makes you look lame
0 · Reply
Dkll303
Dkll303 Jul. 8 at 11:30 AM
$AGIO and…..drum roll…..guess, PM ! RED …..RED ….2887 days of FOUSE and RED On 200 shares ..hahaha
0 · Reply
Tumble51
Tumble51 Jul. 8 at 12:00 AM
$AGIO How did the Sea of Red do today ? Tell the board @Whiskey1679 Dave-EE Boy …lol RED AGAIN..LIKE THE LAST 7 years , lol Nice try…. Did you see a golden cross in your whiskey glass ??
0 · Reply
Jadek6
Jadek6 Jul. 7 at 4:45 PM
$AGIO good take !! Clearly written by someone in the know of the clowns at this biotech
0 · Reply
Tumble51
Tumble51 Jul. 7 at 2:24 PM
$AGIO puff piece a YUGE FLOP
0 · Reply
Tumble51
Tumble51 Jul. 7 at 2:18 PM
$AGIO Hahahaha ..BUY IT UP, @Whiskey1697 !! The whole float , hahaha
0 · Reply
Tumble51
Tumble51 Jul. 7 at 1:48 PM
$ADM $AGIO Ya better listen to the RED GURU !!!!
1 · Reply
Tumble51
Tumble51 Jul. 7 at 12:56 PM
0 · Reply
Tumble51
Tumble51 Jul. 7 at 11:35 AM
$AGIO oh ya, Dec 2024 at $60 and in 6 months still $35 Ya, it is a winner , the puff piece here written is $10,000 price tag to BioTechHealthX
0 · Reply
Tumble51
Tumble51 Jul. 7 at 11:33 AM
$ADM $AGIO $GNS $NVDA $SBET and his pick , lol of AGIO Already RED PREMARKET Oh , sign me up for his wisdom !!!
0 · Reply